Discovery of a novel class of 2-aminopyrimidines as CDK1 and CDK2 inhibitors.
Jinho Lee, Kyoung-Hee Kim, Shinwu Jeong
Index: Bioorg. Med. Chem. Lett. 21(14) , 4203-5, (2011)
Full Text: HTML
Abstract
A series of new 2-(2-aminopyrimidin-4-yl)phenol derivatives were synthesized as potential antitumor compounds. Substitution with pyrrolidine-3,4-diol at the 4-position of phenol provided potent inhibitory activity against CDK1 and CDK2. X-ray crystal structural studies were performed to account for the effect of the substituent on both the enzymatic and cell growth inhibitory activities.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
Cocrystals of 5-fluorocytosine. I. Coformers with fixed hydrogen-bonding sites.
2012-08-01
[Acta Crystallogr. B 68(Pt 4) , 431-43, (2012)]
Synthesis and Structural Study of Some Pyrimidinium Hexafluoridosilicates.
2015-01-01
[Acta Chim. Slov. 62 , 297-303, (2015)]
2010-01-01
[Eur. J. Med. Chem. 45 , 379-86, (2010)]
Assessment of antiplatelet activity of 2-aminopyrimidines.
2012-04-01
[Eur. J. Med. Chem. 50 , 428-32, (2012)]
2-Aminopyrimidine as a novel scaffold for biofilm modulation.
2012-04-07
[Org. Biomol. Chem. 10(13) , 2552-61, (2012)]